Licensed for type-2 diabetes. (Other GPL1ra are licensed for adjunct in weight loss). GLP-1ra reduce dementia in type-2 diabetes.79 Cognition meta-analysis for any GLP1: OR 1.82 (0.95-3.50), N=7732.80 No cSVD data. Adherence 69.7% at 12 months.81 This evidence concerns the gene GLP1R and dementia.